Prognostic and clinicopathological differences of DcR3 in gastrointestinal cancer: evidence from meta-analysis.
about
Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis.Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis.Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
P2860
Prognostic and clinicopathological differences of DcR3 in gastrointestinal cancer: evidence from meta-analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prognostic and clinicopatholog ...... : evidence from meta-analysis.
@en
type
label
Prognostic and clinicopatholog ...... : evidence from meta-analysis.
@en
prefLabel
Prognostic and clinicopatholog ...... : evidence from meta-analysis.
@en
P2093
P2860
P1476
Prognostic and clinicopatholog ...... r: evidence from meta-analysis
@en
P2093
P2860
P304
P577
2014-09-15T00:00:00Z